Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Open accessThe DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The interrogation of proteomes ("proteomics") in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology and medicine. METHODOLOGY/PRINCIPAL FINDINGS: We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 µL of serum or plasma). Our current assay measures 813 proteins with low limits of detection (1 pM median), 7 logs of overall dynamic range (~100 fM-1 µM), and 5% median coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding signature of DNA aptamer concentrations, which is quantified on a DNA microarray. Our assay takes advantage of the dual nature of aptamers as both folded protein-binding entities with defined shapes and unique nucleotide sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to rapidly discover unique protein signatures characteristic of various disease states. CONCLUSIONS/SIGNIFICANCE: We describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Major developments in mass spectrometry-based, antibody-based and aptamer-based proteomics over the past decade have enabled the robust quantification of thousands of proteins in single samples87–90.”
From Measuring biological age using omics data (2022) · cites this paper as [89]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The assay uses DNA-based slow off-rate modified aptamers (SOMAmerTM reagents) to quantify the relative abundance of approximately 7000 proteins with high specificity and limits of detection largely comparable to antibody-based assays.”
From Cross-ancestry comparison of aptamer and antibody protein measures (2026) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteomic technologies, including mass spectrometry–based proteomics, aptamer-based arrays (SomaLogic), and proximity extension assay technology (Olink), are now available for the large-scale quantification and validation of thousands of proteins in human biological fluids or tissues (122–127).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RNA-Mediated Metal-Metal Bond Formation in the Synthesis of Hexagonal Palladium Nanoparticles
Gugliotti, L. A., Feldheim, D. L., & Eaton, B. E. (2004) · Science · doi:10.1126/science.1095678 · Cited by 197 · cited 2×
“This innovation was used to select catalysts, including the first RNA-catalyzed carbon-carbon bond formation [16,23].”
MethodSelf-citationRetractedLevey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialSelf-citationIn vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialKeller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830 · cited 2×
“0% probability as specified by the Peptide Prophet algorithm [45].”
MethodA Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809 · cited 3×
“Protein probabilities were assigned by the Protein Prophet algorithm [44].”
MethodAssessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 2×
“Eleven subjects had early-stage CKD based on estimated GFR (Table 3) (eGFR, defined as stages 1–2, median creatinine clearance 70 ml/min/m, range 62–97 ml/min/m) and 31 had late-stage CKD (stages 3–5, median creatinine clearance 25 ml/min/m, range 7–49 ml/min/m) [33].”
BackgroundPegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 1×
“Aptamers are a class of nucleic acid-based molecules discovered twenty years ago [13,14] and have since been employed in diverse applications including therapeutics [15], catalysis [16], and now proteomics.”
BackgroundHopfield, J. J. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.4135 · Cited by 1,594 · cited 2×
“Inspired by classic kinetic theory of specific binding in complex mixtures [25,26], we employed kinetic manipulations to help overcome the problem of non-specific SOMAmer-protein binding.”
MethodLevey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516 · cited 4×
“CKD biomarkers could also be useful for monitoring disease progression and guiding treatment [28–31].”
BackgroundInfluential
Cited by
Items 101–200 of 1,009
Alternative affinity tools: more attractive than antibodies?
Ruigrok, V. J. B., Levisson, M., Eppink, M. H. M., Smidt, H., & van der Oost, J. (2011) · Biochemical Journal · doi:10.1042/bj20101860 · Cited by 194
Sanghavi, B. J., Moore, J. A., Chávez, J. L., Hagen, J. A., Kelley-Loughnane, N., Chou, C.-F., & Swami, N. S. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.11.044 · Cited by 191
Connecting aging biology and inflammation in the omics era
Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158448 · Cited by 189
Kiddle, S. J., Sattlecker, M., Proitsi, P., Simmons, A., Westman, E., Bazenet, C., Nelson, S. K., Williams, S., Hodges, A., Johnston, C., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130380 · Cited by 189
Self-citationBiomarkers and Detection Platforms for Human Health and Performance Monitoring: A Review
Sim, D., Brothers, M. C., Slocik, J. M., Islam, A. E., Maruyama, B., Grigsby, C. C., Naik, R. R., & Kim, S. S. (2022) · Advanced Science · doi:10.1002/advs.202104426 · Cited by 186
Dammer, E. B., Ping, L., Duong, D. M., Modeste, E. S., Seyfried, N. T., Lah, J. J., Levey, A. I., & Johnson, E. C. B. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01113-5 · Cited by 188
Brown, A., Brill, J., Amini, R., Nurmi, C., & Li, Y. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202318665 · Cited by 175
Simple Methods and Rational Design for Enhancing Aptamer Sensitivity and Specificity
Kalra, P., Dhiman, A., Cho, W. C., Bruno, J. G., & Sharma, T. K. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00041 · Cited by 184
Inside the Black Box: What Makes SELEX Better?
Komarova, N., & Kuznetsov, A. (2019) · Molecules · doi:10.3390/molecules24193598 · Cited by 181
Comparison of Proteomic Assessment Methods in Multiple Cohort Studies
Raffield, L. M., Dang, H., Pratte, K. A., Jacobson, S., Gillenwater, L. A., Ampleford, E., Barjaktarevic, I., Basta, P., Clish, C. B., Comellas, A. P., et al. (2020) · PROTEOMICS · doi:10.1002/pmic.201900278 · Cited by 184
Ali, M. H., Elsherbiny, M. E., & Emara, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102511 · Cited by 181
Aptamers and Their Applications in Nanomedicine
Sun, H., & Zu, Y. (2015) · Small · doi:10.1002/smll.201403073 · Cited by 180
Recent Progress and Opportunities for Nucleic Acid Aptamers
Byun, J. (2021) · Life · doi:10.3390/life11030193 · Cited by 177
Advancements in Aptamer Discovery Technologies
Gotrik, M. R., Feagin, T. A., Csordas, A. T., Nakamoto, M. A., & Soh, H. T. (2016) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00283 · Cited by 177
Mechanistic Challenges and Advantages of Biosensor Miniaturization into the Nanoscale
Soleymani, L., & Li, F. (2017) · ACS Sensors · doi:10.1021/acssensors.7b00069 · Cited by 177
ABCs of DNA aptamer and related assay development
Sharma, T. K., Bruno, J. G., & Dhiman, A. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.01.003 · Cited by 174
Lindsey, M. L., Mayr, M., Gomes, A. V., Delles, C., Arrell, D. K., Murphy, A. M., Lange, R. A., Costello, C. E., Jin, Y.-F., Laskowitz, D. T., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000226 · Cited by 175
Assembling DNA through Affinity Binding to Achieve Ultrasensitive Protein Detection
Zhang, H., Li, F., Dever, B., Wang, C., Li, X., & Le, X. C. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201210022 · Cited by 175
Current and Prospective Protein Biomarkers of Lung Cancer
Zamay, T., Zamay, G., Kolovskaya, O., Zukov, R., Petrova, M., Gargaun, A., Berezovski, M., & Kichkailo, A. (2017) · Cancers · doi:10.3390/cancers9110155 · Cited by 174
Perspective on the Future Role of Aptamers in Analytical Chemistry
Wu, Y., Belmonte, I., Sykes, K. S., Xiao, Y., & White, R. J. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03853 · Cited by 173
Aptamer-based biosensors: from SELEX to biomedical diagnostics
Stangherlin, S., Lui, N., Lee, J. H., & Liu, J. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118349 · Cited by 168
G-quadruplex-based aptamers against protein targets in therapy and diagnostics
Platella, C., Riccardi, C., Montesarchio, D., Roviello, G. N., & Musumeci, D. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.11.027 · Cited by 170
Stability and reproducibility of proteomic profiles measured with an aptamer-based platform
Kim, C. H., Tworoger, S. S., Stampfer, M. J., Dillon, S. T., Gu, X., Sawyer, S. J., Chan, A. T., Libermann, T. A., & Eliassen, A. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-26640-w · Cited by 170
Analysis of In Vitro Aptamer Selection Parameters
McKeague, M., McConnell, E. M., Cruz-Toledo, J., Bernard, E. D., Pach, A., Mastronardi, E., Zhang, X., Beking, M., Francis, T., Giamberardino, A., et al. (2015) · Journal of Molecular Evolution · doi:10.1007/s00239-015-9708-6 · Cited by 168
Ozer, A., Pagano, J. M., & Lis, J. T. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.34 · Cited by 168
Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia
Lertudomphonwanit, C., Mourya, R., Fei, L., Zhang, Y., Gutta, S., Yang, L., Bove, K. E., Shivakumar, P., & Bezerra, J. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8462 · Cited by 166
Structural Insights into the Processing of Nucleobase-Modified Nucleotides by DNA Polymerases
Hottin, A., & Marx, A. (2016) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00544 · Cited by 163
Jiang, Y., Zhou, X., Ip, F. C., Chan, P., Chen, Y., Lai, N. C. H., Cheung, K., Lo, R. M. N., Tong, E. P. S., Wong, B. W. Y., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12369 · Cited by 162
Padinharayil, H., Varghese, J., John, M. C., Rajanikant, G. K., Wilson, C. M., Al-Yozbaki, M., Renu, K., Dewanjee, S., Sanyal, R., Dey, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.07.023 · Cited by 159
Spellman, D. S., Wildsmith, K. R., Honigberg, L. A., Tuefferd, M., Baker, D., Raghavan, N., Nairn, A. C., Croteau, P., Schirm, M., Allard, R., et al. (2015) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201400178 · Cited by 161
“…several approaches and technologies currently being employed to interrogate large numbers of proteins such as multiplexed immunoassays[26], protein arrays[27], and aptamer arrays [28] to name a few, MS has emerged as the most widely adopted technology platform for proteomics in biomedical research.”
COVID-19 therapeutics: Challenges and directions for the future
Robinson, P. C., Liew, D. F. L., Tanner, H. L., Grainger, J. R., Dwek, R. A., Reisler, R. B., Steinman, L., Feldmann, M., Ho, L.-P., Hussell, T., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119893119 · Cited by 161
Rhodes, C. J., Wharton, J., Ghataorhe, P., Watson, G., Girerd, B., Howard, L. S., Gibbs, J. S. R., Condliffe, R., Elliot, C. A., Kiely, D. G., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30161-3 · Cited by 160
Haslam, D. E., Li, J., Dillon, S. T., Gu, X., Cao, Y., Zeleznik, O. A., Sasamoto, N., Zhang, X., Eliassen, A. H., Liang, L., et al. (2022) · PROTEOMICS · doi:10.1002/pmic.202100170 · Cited by 157
Elskens, J. P., Elskens, J., & Madder, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124522 · Cited by 178
Extended gate field-effect-transistor for sensing cortisol stress hormone
Sheibani, S., Capua, L., Kamaei, S., Akbari, S. S. A., Zhang, J., Guerin, H., & Ionescu, A. M. (2021) · Communications Materials · doi:10.1038/s43246-020-00114-x · Cited by 158
Webber, J., Stone, T. C., Katilius, E., Smith, B. C., Gordon, B., Mason, M. D., Tabi, Z., Brewis, I. A., & Clayton, A. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.032136 · Cited by 153
Self-citationHigh-throughput proteomics and AI for cancer biomarker discovery
Xiao, Q., Zhang, F., Xu, L., Yue, L., Kon, O. L., Zhu, Y., & Guo, T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113844 · Cited by 161
Gupta, S., Hirota, M., Waugh, S. M., Murakami, I., Suzuki, T., Muraguchi, M., Shibamori, M., Ishikawa, Y., Jarvis, T. C., Carter, J. D., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532580 · Cited by 151
Self-citationA Versatile Approach Towards Nucleobase‐Modified Aptamers
Tölle, F., Brändle, G. M., Matzner, D., & Mayer, G. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201503652 · Cited by 166
Modified nucleic acids: replication, evolution, and next-generation therapeutics
Duffy, K., Arangundy‐Franklin, S., & Holliger, P. (2020) · BMC Biology · doi:10.1186/s12915-020-00803-6 · Cited by 166
Fajgenbaum, D. C., Langan, R.-A., Japp, A. S., Partridge, H. L., Pierson, S. K., Singh, A., Arenas, D. J., Ruth, J. R., Nabel, C. S., Stone, K., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126091 · Cited by 147
“Proteomic quantifications were performed in accordance with previously published methods for Myriad RBM DiscoveryMAP v.3.3 (41), a multiplex immunoassay that quantifies the levels of 315 analytes, and SomaLogic SOMAscan (42), a modified DNA-aptamer approach that quantifies 1129 analytes.”
BackgroundInfluentialJuncker, D., Bergeron, S., Laforte, V., & Li, H. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.11.012 · Cited by 164
Liu, J., Chang, H.-W., Huang, Z.-M., Nakamura, M., Sekhon, S., Ahn, R., Munoz-Sandoval, P., Bhattarai, S., Beck, K. M., Sanchez, I. M., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.11.028 · Cited by 143
The Molecular Basis of Predicting Atherosclerotic Cardiovascular Disease Risk
Nayor, M. G., Brown, K., & Vasan, R. S. (2021) · Circulation Research · doi:10.1161/circresaha.120.315890 · Cited by 163
Aptasensors versus immunosensors—Which will prevail?
Arshavsky‐Graham, S., Heuer, C., Xin, J., & Segal, E. (2022) · Engineering in Life Sciences · doi:10.1002/elsc.202100148 · Cited by 160
Circulating Proteomic Signatures of Chronological Age
Menni, C., Kiddle, S. J., Mangino, M., Viñuela, A., Psatha, M., Steves, C., Sattlecker, M., Buil, A., Newhouse, S., Nelson, S., et al. (2015) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu121 · Cited by 144
Self-citationMolecular Elucidation of Disease Biomarkers at the Interface of Chemistry and Biology
Zhang, L., Wan, S., Jiang, Y. Y., Wang, Y., Fu, T., Liu, Q., Cao, Z., Qiu, L., & Tan, W. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b10646 · Cited by 146
Cell type-selective secretome profiling in vivo
Wei, W., Riley, N. M., Yang, A. C., Kim, J. T., Terrell, S. M., Li, V. L., Garcia-Contreras, M., Bertozzi, C. R., & Long, J. Z. (2021) · Nature Chemical Biology · doi:10.1038/s41589-020-00698-y · Cited by 140
Aptamers from random sequence space: Accomplishments, gaps and future considerations
Qian, S., Chang, D., He, S., & Li, Y. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.339511 · Cited by 162
Welton, J. L., Loveless, S., Stone, T., von Ruhland, C., Robertson, N. P., & Clayton, A. (2017) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2017.1369805 · Cited by 142
Integrated trajectories of the maternal metabolome, proteome, and immunome predict labor onset
Stelzer, I. A., Ghaemi, M. S., Han, X., Ando, K., Hedou, J. J., Feyaerts, D., Peterson, L. S., Rumer, K. K., Tsai, E. S., Ganio, E. A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd9898 · Cited by 156
Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome
Walitt, B. T., Singh, K., LaMunion, S. R., Hallett, M., Jacobson, S., Chen, K. Y., Enose‐Akahata, Y., Apps, R., Barb, J. J., Bédard, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45107-3 · Cited by 168
Yang, K.-A., Barbu, M., Halim, M., Pallavi, P., Kim, B. B., Kolpashchikov, D. M., Pecic, S., Taylor, S. K., Worgall, T. S., & Stojanović, M. N. (2014) · Nature Chemistry · doi:10.1038/nchem.2058 · Cited by 141
Inferring Interaction Networks From Multi-Omics Data
Hawe, J. S., Theis, F. J., & Heinig, M. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00535 · Cited by 169
Next generation plasma proteome profiling to monitor health and disease
Zhong, W., Edfors, F., Gummesson, A., Bergström, G., Fagerberg, L., & Uhlén, M. (2021) · Nature Communications · doi:10.1038/s41467-021-22767-z · Cited by 140
Proteomics in aging research: A roadmap to clinical, translational research
Moaddel, R., Ubaida‐Mohien, C., Tanaka, T., Lyashkov, A., Basisty, N., Schilling, B., Semba, R. D., Franceschi, C., Gorospe, M., & Ferrucci, L. (2021) · Aging Cell · doi:10.1111/acel.13325 · Cited by 139
Ostroff, R. M., Mehan, M. R., Stewart, A., Ayers, D., Brody, E. N., Williams, S. A., Levin, S., Black, B., Harbut, M., Carbone, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046091 · Cited by 138
Self-citationMatsunaga, K., Kimoto, M., & Hirao, I. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b10767 · Cited by 136
The prediction of early preeclampsia: Results from a longitudinal proteomics study
Tarca, A. L., Romero, R. J., Benshalom-Tirosh, N., Than, N. G., Gudicha, D. W., Done, B., Pacora, P., Chaiworapongsa, T., Panaitescu, B., Tirosh, D., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217273 · Cited by 152
Messner, C. B., Demichev, V., Wang, Z., Hartl, J., Kustatscher, G., Mülleder, M., & Ralser, M. (2022) · PROTEOMICS · doi:10.1002/pmic.202200013 · Cited by 154
Modern affinity reagents: Recombinant antibodies and aptamers
Groff, K., Brown, J., & Clippinger, A. J. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.10.004 · Cited by 163
Particle Display: A Quantitative Screening Method for Generating High‐Affinity Aptamers
Wang, J., Gong, Q., Maheshwari, N., Eisenstein, M. S., Arcila, M. L., Kosik, K. S., & Soh, H. T. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309334 · Cited by 135
Goeminne, L. J. E., Vladimirova, A., Eames, A., Tyshkovskiy, A., Argentieri, M. A., Ying, K., Moqri, M., & Gladyshev, V. N. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2024.10.005 · Cited by 125
Antibody‐based proteomics and biomarker research—Current status and limitations
Solier, C., & Langen, H. (2014) · PROTEOMICS · doi:10.1002/pmic.201300334 · Cited by 145
Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation
Shigdar, S. L., MacDonald, J. P., O'Connor, M., Wang, T., Xiang, D., Shamaileh, H. A., Qiao, L., Wei, M. Q., Zhou, S., Zhu, Y., et al. (2013) · Sensors · doi:10.3390/s131013624 · Cited by 128
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Zarkali, A., Thomas, G. E. C., Zetterberg, H., & Weil, R. S. (2024) · Nature Communications · doi:10.1038/s41467-024-49949-9 · Cited by 147
Selection and analytical applications of aptamers binding microbial pathogens
Hamula, C. L. A., Zhang, H., Li, F., Wang, Z., Le, X. C., & Li, X. (2011) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2011.08.006 · Cited by 128
Siddharth, J., Chakrabarti, A., Pannérec, A., Karaz, S., Morin-Rivron, D., Masoodi, M., Feige, J. N., & Parkinson, S. J. (2017) · Aging · doi:10.18632/aging.101262 · Cited by 127
Watkins, Z., Karajić, A., Young, T., White, R. J., & Heikenfeld, J. C. (2023) · ACS Sensors · doi:10.1021/acssensors.2c02403 · Cited by 143
Proteomic biomarkers in kidney disease: issues in development and implementation
Mischak, H., Delles, C., Vlahou, A., & Vanholder, R. C. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.247 · Cited by 137
Ferguson, J. F., Allayee, H., Gerszten, R. E., Ideraabdullah, F., Kris-Etherton, P. M., Ordovás, J. M., Rimm, E. B., Wang, T. J., & Bennett, B. J. (2016) · Circulation: Cardiovascular Genetics · doi:10.1161/hcg.0000000000000030 · Cited by 123
Wolf, J., Rasmussen, D. K., Sun, Y. J., Vu, J. T., Wang, E., Espinosa, C. A., Bigini, F., Chang, R. T., Montague, A. A., Tang, P. H., et al. (2023) · Cell · doi:10.1016/j.cell.2023.09.012 · Cited by 140
Mistimed food intake and sleep alters 24-hour time-of-day patterns of the human plasma proteome
Depner, C. M., Melanson, E. L., McHill, A. W., & Wright, K. P. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714813115 · Cited by 122
“Briefly, each of the 1,129 proteins analyzed has its own binding reagent made from chemically modified ssDNA, termed “modified aptamers” (65).”
BackgroundThe prediction of late-onset preeclampsia: Results from a longitudinal proteomics study
Erez, O., Romero, R. J., Maymon, E., Chaemsaithong, P., Done, B., Pacora, P., Panaitescu, B., Chaiworapongsa, T., Hassan, S. S., & Tarca, A. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181468 · Cited by 136
Oh, H. S.-H., Urey, D. Y., Karlsson, L., Zhu, Z., Shen, Y., Farinas, A., Timsina, J., Duggan, M. R., Chen, J., Guldner, I. H., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03565-2 · Cited by 121
Current applications of antibody microarrays
Chen, Z., Dodig‐Crnković, T., Schwenk, J. M., & Tao, S. (2018) · Clinical Proteomics · doi:10.1186/s12014-018-9184-2 · Cited by 136
An SFTPC BRICHOS mutant links epithelial ER stress and spontaneous lung fibrosis
Katzen, J. B., Wagner, B. D., Venosa, A., Kopp, M. C., Tomer, Y., Russo, S. J., Headen, A. C., Basil, M. C., Stark, J. M., Mulugeta, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126125 · Cited by 137
Genetic alphabet expansion technology by creating unnatural base pairs
Kimoto, M., & Hirao, I. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00457j · Cited by 129
Evoking picomolar binding in RNA by a single phosphorodithioate linkage
Abeydeera, N., Egli, M., Cox, N., Mercier, K., Conde, J. N., Pallan, P. S., Mizurini, D. M., Sierant, M., Hibti, F.-E., Hassell, T., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw725 · Cited by 122
Aptamers: versatile molecular recognition probes for cancer detection
Sun, H., Tan, W., & Zu, Y. (2016) · The Analyst · doi:10.1039/c5an01995h · Cited by 135
Circulating Protein Signatures and Causal Candidates for Type 2 Diabetes
Gudmundsdottir, V., Zaghlool, S. B., Emilsson, V., Aspelund, T., Ilkov, M., Gudmundsson, E. F., Jonsson, S. M., Zilhão, N. R., Lamb, J. R., Suhre, K., et al. (2020) · Diabetes · doi:10.2337/db19-1070 · Cited by 117
Aptamers and SELEX in Chemistry & Biology
Famulok, M., & Mayer, G. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.003 · Cited by 118
Fit for the Eye: Aptamers in Ocular Disorders
Drolet, D. W., Green, L. S., Gold, L., & Janjić, N. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0573 · Cited by 130
Self-citationEpigenetic scores for the circulating proteome as tools for disease prediction
Gadd, D. A., Hillary, R. F., McCartney, D. L., Zaghlool, S. B., Stevenson, A. J., Cheng, Y., Fawns‐Ritchie, C., Nangle, C., Campbell, A., Flaig, R., et al. (2022) · eLife · doi:10.7554/elife.71802 · Cited by 136
Quantitative selection and parallel characterization of aptamers
Cho, M., Oh, S. S., Nie, J., Stewart, R. M., Eisenstein, M. S., Chambers, J., Marth, J. D., Walker, F. M., Thomson, J. A., & Soh, H. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315866110 · Cited by 116
Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight
Lee, S.-J., Lehar, A., Meir, J. U., Koch, C., Morgan, A., Warren, L. E., Rydzik, R., Youngstrom, D. W., Chandok, H., George, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014716117 · Cited by 115
“We carried out proteomic analysis of plasma using the SomaScan assay, which uses aptamers to measure relative levels of over 5,000 secreted proteins (31).”
Lipi, F., Chen, S., Chakravarthy, M., Rakesh, S., & Veedu, R. N. (2016) · RNA Biology · doi:10.1080/15476286.2016.1236173 · Cited by 127
Kahal, H., Halama, A., Aburima, A. A., Bhagwat, A. M., Butler, A. E., Graumann, J., Suhre, K., Sathyapalan, T., & Atkin, S. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-61531-z · Cited by 125
Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers
Mercier, M.-C., Dontenwill, M., & Choulier, L. (2017) · Cancers · doi:10.3390/cancers9060069 · Cited by 113
“[29] demonstrated that the success rate of a conventional SELEX on difficult proteins is lower than 30% and improved this rate up to 84%, by the incorporation of four modified nucleotide triphosphate analogs: 5-benzylaminocarbonyl-dU(BndU), 5-naphthylmethylaminocarbonyl-dU (NapdU), 5- tryptaminocarbonyl-dU (TrpdU), an…”
BackgroundProgress and Trends in Complement Therapeutics
Ricklin, D., & Lambris, J. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4118-2_1 · Cited by 119
Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment
Groote, M. A. D., Nahid, P., Jarlsberg, L. G., Johnson, J. L., WEINER, M. H., Muzanyi, G., Janjić, N., Sterling, D. G., & Ochsner, U. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061002 · Cited by 127
Self-citationProteomic Analysis of Human Plasma during Intermittent Fasting
Harney, D., Hutchison, A. T., Hatchwell, L., Humphrey, S. J., James, D. E., HOCKING, S. L., Heilbronn, L. K., & Larance, M. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00090 · Cited by 116
Cruchaga, C., Western, D., Timsina, J., Wang, L., Wang, C., Yang, C., Ali, M., Beric, A., Gorijala, P., Kohlfeld, P., et al. (2023) · doi:10.21203/rs.3.rs-2814616/v1 · Cited by 112
Western, D., Timsina, J., Wang, L., Wang, C., Yang, C., Phillips, B., Wang, Y., Liu, M., Ali, M., Beric, A., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01972-8 · Cited by 111
“We integrated our pQTLs with AD GWAS and prioritized 38 proteins, 24 of which were not nominated by previous studies.”
Takahashi, M. M., Wu, X., Ho, M., Chomchan, P., Rossi, J. J., Burnett, J., & Zhou, J. (2016) · Scientific Reports · doi:10.1038/srep33697 · Cited by 111
A Pilot Characterization of the Human Chronobiome
Skarke, C., Lahens, N. F., Rhoades, S. D., Campbell, A., Bittinger, K., Bailey, A., Hoffmann, C., Olson, R. S., Chen, L., Yang, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17362-6 · Cited by 108
Age-Dependent Changes in the Cerebrospinal Fluid Proteome by Slow Off-Rate Modified Aptamer Array
Baird, G. S., Nelson, S. K., Keeney, T. R., Stewart, A., Williams, S., Kraemer, S., Peskind, E. R., & Montine, T. J. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.024 · Cited by 110
Self-citationBeyond antibodies: New affinity reagents to unlock the proteome
Lollo, B., Steele, F., & Gold, L. (2014) · PROTEOMICS · doi:10.1002/pmic.201300187 · Cited by 110
Self-citationGeneration of Aptamers with an Expanded Chemical Repertoire
Diafa, S., & Hollenstein, M. (2015) · Molecules · doi:10.3390/molecules200916643 · Cited by 121
Engineering Aptamer Switches for Multifunctional Stimulus‐Responsive Nanosystems
Rangel, A. E., Hariri, A. A., Eisenstein, M. S., & Soh, H. T. (2020) · Advanced Materials · doi:10.1002/adma.202003704 · Cited by 112
Metadata
- Authors
- Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., Flather, D., Forbes, A., Foreman, T., Fowler, C., Gawande, B., Goss, M., Gunn, M., Gupta, S., Halladay, D., Heil, J., Heilig, J., Hicke, B., Husar, G., Janjic, N., Jarvis, T., Jennings, S., Katilius, E., Keeney, T. R., Kim, N., Koch, T. H., Kraemer, S., Kroiss, L., Le, N., Levine, D., Lindsey, W., Lollo, B., Mayfield, W., Mehan, M., Mehler, R., Nelson, S. K., Nelson, M., Nieuwlandt, D., Nikrad, M., Ochsner, U., Ostroff, R. M., Otis, M., Parker, T., Pietrasiewicz, S., Resnicow, D. I., Rohloff, J., Sanders, G., Sattin, S., Schneider, D., Singer, B., Stanton, M., Sterkel, A., Stewart, A., Stratford, S., Vaught, J. D., Vrkljan, M., Walker, J. J., Watrobka, M., Waugh, S., Weiss, A., Wilcox, S. K., Wolfson, A., Wolk, S. K., Zhang, C., & Zichi, D.
- Affiliations
- University of Colorado Boulder (US)
- SomaLogic (United States) (US)
- Cornell University (US)
- Corresponding author
- Gold, Larry
- Walker, Jeffrey J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-07
- Volume
- 5
- Issue
- 12
- Pages
- e15004
- ISSN
- 1756-0357 (ISSN-L)
- 1932-6203
- PMC
- PMC3000457
- OpenAlex
- W2084373725
- Cited by
- 1,754
- References
- 46
- Citations by year
- 2026: 164 · 2025: 190 · 2024: 170 · 2023: 154 · 2022: 184 · 2021: 127 · 2020: 115 · 2019: 105 · 2018: 95 · 2017: 98 · 2016: 78 · 2015: 73 · 2014: 60 · 2013: 56 · 2012: 50
- Type
- posted content
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Nature Precedings (publishedVersion, cc-by)
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Nature Precedings (submittedVersion)
- Funders
- University of Washington
- National Institutes of Health
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- aptamer-based proteomics, biomarker discovery, chemically modified nucleotides, DNA microarrays, plasma protein profiling, chronic kidney disease, multiplexed protein quantification, aptamer selection, disease biomarkers
- MeSH terms
- Aged, Female, Genetic Techniques, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Kinetics, Male, Middle Aged, Nucleic Acid Hybridization, Mass Spectrometry, Reproducibility of Results, Biomarkers, Gene Library, Evidence-Based Medicine, Oligonucleotide Array Sequence Analysis, Proteome, Proteomics, Aptamers, Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.